Not only did I read it, I cut and pasted my last post directly from it.
Regardless of the 6/7 patient ICS data, it clearly states that the presentation of the interim results from Phase 2b trials will cover PFS as well as safety data, so there's your first mistake.
It also gives the total trial enrollment as 63 patients, so there's your second mistake.
it also states that the triall enrollment was completed in September 2011.
Three strikes and your out!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $225.8K | 931.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 288990 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 21838 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |